Skip to main content
. 2017 May 4;8:723. doi: 10.3389/fmicb.2017.00723

Table 1.

Proteins identified in the immunoreactive bands from the two Brachyspira species.

Band ida Sample Specificb Observed Mass (kDa) Protein identified
12% 7.5% Accessionc Name Theor. Mass (kDa)
2 OLA9 X 86 76 D8ICZ7 Elongation factor G 75.8
3 OLA9 83 D8IDC2 Uncharacterized protein 62
4 ATCCBP X 81 78 D8ICZ7 Elongation factor G 75.8
5* OLA9 X 78 72 J9UT37 Putative polymerase 72.3
D8IEM8/A0A0G4K4U5 Chaperone protein HtpG 73.9
D8IBS0 Chaperone protein DnaK 67.6
6 ATCCBP 77 D8IDC2 Uncharacterized protein 62
7 OLA9 75 D8IDC2 Uncharacterized protein 62.1
9 V1 73 G0EJY7 Uncharacterized protein 65.4
10* ATCCBP X 72 70 D8IEM8 Chaperone protein HtpG 73.9
J9UT37 Putative polymerase 72.3
D8ICG5 Uncharacterized protein 85
12 V1 72 C0R0R7 Putative treponemal membrane protein 63.9
13 OLA9 X 72 68 D8IE58 Aspartyl-tRNA synthase 67.5
15 ATCCBP 69 D8IDC2 Uncharacterized protein 62.1
16 ATCCBP X 69 D8IFS5 Phosphoenol pyruvate carboxykinase 67.5
17 ATCCBP X 69 70 D8IE58 Aspartyl-tRNA synthase 67.5
18 V1 X 68 C0R0E5 Phosphoenol pyruvate carboxykinase 67.5
19 OLA9 X 65 D8I9T6 Biotin lipoyl 65
20 OLA9 64 61 D8IB78 60 kDa chaperonin 58.1
22 ATCCBP X 63 D8I9T6 Biotin lipoyl 65.0
24 ATCCBP 62 61 D8IB78 60 kDa chaperonin 58.1
25 V1 61 C0QWH4 60 kDa chaperonin 58.2
26* OLA9 X 58 53 J9USS2 60 kDa chaperonin 58.1
D8IAM3 Amidohydrolase 3 60.6
J9UU81 2-isopropylmalate synthase 54.4
D8IF78 Outer membrane efflux protein 54.7
D8IDP7 Trigger factor, C-terminal domain protein 50.6
27 OLA9 X 57 D8IBK7 TmpB outer membrane protein 42.5
28 ATCCBP X 56 55 K0JIZ9 Carboxyl terminal protease 54.9
29* ATCCBP X 54 D8IBK7 TmpB outer membrane protein 42.4
31 ATCCBP X 51 50 D8IBH9 ATP synthase subunit beta 45.6
32 ATCCBP X* 50 D8IET2 Enolase 47
36 V1 X 45 C0QW84 Uncharacterized protein 38.6
37 OLA9 44 Q9FA06 Putative elongation factor Tu 16.3
D8ICZ6 Elongation factor Tu 44.8
38 ATCCBP 44 Q9FA06 Putative elongation factor Tu 16.3
D8ICZ6 Elongation factor Tu 44.8
39 ATCCBP X 44 D8ICG3 Uncharacterized protein 38.9
40 OLA9 X 43 42 D8IBY6 FlaA 35.7
41 V1 43 C0QVZ4 Elongation factor Tu 44.7
Q9FA06 Putative elongation factor Tu 16.3
42 V1 42 C0QXS8 NADH oxidase 50.5
C0QVZ4 Elongation factor Tu 44.7
43 V1 42 C0R0T5 FlaA 24.5
P32520 FlaA1 36
44 ATCCBP X 41 D8IBY6 FlaA 35.7
45 OLA9 X 40 38 D8ICU0 VspD 42.7
46* ATCCBP X 38 38 D8ICU0 VspD 42.7
J9TU32 Ribonucleotide-diphosphate reductase subunit beta 41.1
D8IEW7 Mannose-1-phosphate guanylyltransferase 40.5
J9URY6 2-oxoacid:ferredoxin oxidoreductase subunit alpha-like protein 82.8
J9UBH8 ATP-dependent 6-phosphofructokinase 34.8
D8ICA2 Toxic anion resistance family protein 40.9
D8I9T4 Uncharacterized protein 39.9
D8ICR1 Pyruvate oxireductase 35.5
47 OLA9 36 D8IAP2 Flagellin FlaB2 32
48 V1 X 35 C0R1L9 UDP-glucose 4 epimerase 36
C0QYC2 Galactose-glucose binding protein 38.2
49 ATCCBP 35 D8IAP2 Flagellin FlaB2 32
50 V1 35 Q26501 FlaB1 32
51* V1 X 35 A0A0H0W3D6 Enolase 47
Q26501 Flagellar protein FlaB1 32
A0A0HOUMF4/G0EJK5 Fructose-bisphosphate aldolase 35.4/35.4
C0QYC2 Methyl-galactoside ABC transporter substrate-binding protein 38.2
C0QZV6 Pseudouridine-5'-phosphate glycosidase 33.9
52 OLA9 X* 33 D8ICA8 Putative FlaA 26.7
53 OLA9 32 K0JHQ4 Flagellin FlaB2 31.3
54 V1 31 P80160 Flagellin FlaB2 31.1
55 ATCCBP 31 K0JHQ4 Flagellin FlaB2 31.3
56 OLA9 29 K0JLS4 Flagellin FlaB3 30
57 V1 X* 29 C0QV52 Enolase 47
Q9F0F6 Flagellin FlaB3 30.4
58 ATCCBP 29 D8IDG1 Flagellin FlaB3 26.6
59 V1 29 Q9F0F6 Flagellin FlaB3 30.4
61 V1 X 26 C0QWY9 Putative FlaAL 24.7
62 ATCCBP X 24 D8ICA7 FlaA-2 24

Complete identification data is available in Supplementary Table S1 (MALDI TOF/TOF) and Supplementary Tables S3S9 (LC-MS/MS). Specific, indicates immunoreactivity is only detected in challenged animals. Observed mass, correspond to the experimental mass calculated from the gel bands. ATCCBP, ATCC 51139 (P43/6/78) B. pilosicoli strain.

a

All identifications by MALDI TOF/TOF except those indicated with an asterisk which were identified by LC-MS/MS.

b

Specific bands with X* have been detected in a control serum with an intensity of one.

c

Group head accession, full data in Supplementary Tables S1, S2.